Skip to main content
High RiskFDAfda-F-1159-2019OTHER

Signature Caf¿ Tomato Basil Bisque Soup: polypropylene cups with linear low density polyethylene caps, and with plastic film seal. NET ...

Category
Units Affected
500
Recall Date
February 25, 2019
Issuing Agency
Hazard
Other

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1159-2019.

A temperature data logger which is intentionally placed into one container of soup to monitor cooling has been misplaced and believed to be in a retail package.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1159-2019.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Albertsons Companies Llc or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1159-2019.

Albertsons Companies LLC

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Albertsons Companies Llc Recall FAQ

Albertsons Companies Llc is the subject of a produce safety report: Signature Caf¿ Tomato Basil Bisque Soup: polypropylene cups with linear low density polyethylene caps, and with plastic film seal. NET .... The notice was published on February 25, 2019 by the U.S. Food and Drug Administration (FDA). Approximately 500 units are potentially affected.